Glen Boyle

Dr. Glen Boyle is Head of the Cancer Drug Mechanisms Group in the Cancer Program, at QIMR Berghofer Medical Research Institute. Boyle established his group in 2013, and was promoted to Senior Research Fellow in February 2015. Boyle has been investigating aspects of melanoma and squamous cell carcinoma biology since 2000, including transcriptional control of melanoma metastasis and perineural invasion of SCC. He has also been involved in pre-clinical studies of a compound currently in Phase I trials for treatment of melanoma, SCC and head and neck cancer.